Analogous to periodontal disease, the pathogenesis of IBD involves aberrant immune system activation [12], with pro-inflammatory mediators, including TNF-α, IL-1β, and IL-6, orchestrating the immune microenvironment and driving disease progression [13,14,15]. This evidence concerns the gene IL6 and inflammatory bowel disease.